NVO
Novo Nordisk A/S
Latest News for NVO
In a report released on May 22, David Evans from Kepler Capital maintained a Hold rating on Novo Nordisk, with a price target of DKK290.00. The com......
Novo Nordisk ( ($NVO) ) just unveiled an announcement. Novo Nordisk said on 22 May 2026 that the European Medicines Agency’s Committee for Medicina......
The latest update is out from Novo Nordisk ( ($NVO) ). On May 22, 2026, Novo Nordisk announced that the European Medicines Agency’s Committee for M......
Novo Nordisk ($NVO) announced an update on their ongoing clinical study. Novo Nordisk is running a phase 3 study called AMAZE 3 to test a new weekl......
Deutsche Bank analyst Emmanuel Papadakis maintained a Hold rating on Novo Nordisk today and set a price target of DKK290.00. Papadakis covers the H......
Novo Nordisk ($NVO) announced an update on their ongoing clinical study. Novo Nordisk A/S has launched a Phase 1 trial titled “Bioequivalence Study......
Novo Nordisk ($NVO) announced an update on their ongoing clinical study. AMAZE 2 is a Phase 3 study run by Novo Nordisk A/S to test a new weekly sh......
Novo Nordisk ($NVO) announced an update on their ongoing clinical study. AMAZE 12 is a Phase 3 trial run by Novo Nordisk A/S that tests a new weekl......
In a report released today, James Gordon CFA from Barclays maintained a Hold rating on Novo Nordisk, with a price target of DKK300.00. According to......
Shares in drugmakers Pfizer ($PFE), Eli Lilly ($LLY), and Novo Nordisk ($NVO) edged lower on Monday afternoon after CNBC’s Megan Cassella revealed ......
News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 40 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NVO | $44.19 | -1.7% | 9.29M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |